High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin

被引:165
作者
Ma, Zengshuan [1 ]
Shayeganpour, Anooshirvan [1 ]
Brocks, Dion R. [1 ]
Lavasanifar, Afsaneh [1 ]
Samuel, John [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada
关键词
curcumin; HPLC; polymeric micelle; pharmacokinetics;
D O I
10.1002/bmc.795
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid and reliable high-performance liquid chromatographic (HPLC) method was developed and validated for the determination of curcumin in rat plasma. Plasma was precipitated with acetonitrile after addition of the internal standard (IS), 4-hydroxybenzophenone. Separation was achieved on a Waters mu Bondapak (TM) C-18 column (3.9 x 300mm, 5 4 mu m) using acetonitrile (55%) and citric buffer, pH 3.0 (45%) as the mobile phase (flow rate = 1.0 mL/min). The UV detection wavelength was 300 and 428 nm for IS and curcumin, respectively. The extraction efficiencies were 97.08, 95.69 and 94.90% for 50, 200 and 1000 ng/mL of curcumin in rat plasma, respectively. The calibration curve was linear over the range 0.02-1 mu g/mL with a correlation coefficient of r(2) > 0.999. The intra- and inter-day coefficients of variation were less than 13%, and mean intra- and inter-day errors were less than +/- 6% at 50, 200 and 1000 ng/mL of curcumin. This assay was successfully applied to the pharmacokinetic studies of both solubilized curcumin and its polymeric micellar formulation in rats. It was found that polymeric micelles increased the half-life of curcumin 162-fold that of solubilized curcumin and increased the volume of distribution (Vd(ss)) by 70-fold. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:546 / 552
页数:7
相关论文
共 24 条
[1]   Micelles of methoxy poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization and controlled delivery of Cyclosporine A [J].
Aliabadi, HM ;
Mahmud, A ;
Sharifabadi, AD ;
Lavasanifar, A .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (02) :301-311
[2]   Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution [J].
Aliabadi, HM ;
Brocks, DR ;
Lavasanifar, A .
BIOMATERIALS, 2005, 26 (35) :7251-7259
[3]  
Atsumi T, 2005, ANTICANCER RES, V25, P4029
[4]   Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase [J].
Belakavadi, M ;
Salimath, BP .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2005, 273 (1-2) :57-67
[5]   Enhanced oral absorption of halofantrine enantiomers after encapsulation in a proliposomal formulation [J].
Brocks, DR ;
Betageri, GV .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (08) :1049-1053
[6]  
Cheng AL, 2001, ANTICANCER RES, V21, P2895
[7]   PHYSIOLOGICAL-PARAMETERS IN LABORATORY-ANIMALS AND HUMANS [J].
DAVIES, B ;
MORRIS, T .
PHARMACEUTICAL RESEARCH, 1993, 10 (07) :1093-1095
[8]   Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation [J].
Gelderblom, H ;
Verweij, J ;
Nooter, K ;
Sparreboom, A .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (13) :1590-1598
[9]   Molecular mechanisms of anti-angiogenic effect of curcumin [J].
Gururaj, AE ;
Belakavadi, M ;
Venkatesh, DA ;
Marmé, D ;
Salimath, BP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 297 (04) :934-942
[10]   NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel [J].
Hamaguchi, T ;
Matsumura, Y ;
Suzuki, M ;
Shimizu, K ;
Goda, R ;
Nakamura, I ;
Nakatomi, I ;
Yokoyama, M ;
Kataoka, K ;
Kakizoe, T .
BRITISH JOURNAL OF CANCER, 2005, 92 (07) :1240-1246